UBS analyst Taylor McGinnis raised the firm’s price target on Bill (BILL) to $65 from $60 and keeps a Buy rating on the shares. Bill’s Q3 print showed signs of macro pressures, and the firm is now modeling 12% year over year core revenue growth for Q4, which assumes further deceleration in core total payment volume per customer growth, the analyst tells investors in a research note. UBS believes slowdown is already embedded in the stock and if there’s any indication that near-term macro concerns are overblown or self-help initiatives materialize, sees upside.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
- Positive Outlook for Bill.com Holdings Amid Mixed Q1 Results and Promising Future Growth
- Bill price target raised to $55 from $50 at Oppenheimer
- Bill price target lowered to $40 from $43 at Wells Fargo
- BILL Holdings Reports Strong Q3 2025 Financial Results
- Bill sees FY25 EPS $2.06-$2.09, consensus $1.95